Financhill
Buy
70

RNA Quote, Financials, Valuation and Earnings

Last price:
$71.25
Seasonality move :
32.33%
Day range:
$71.58 - $71.79
52-week range:
$21.51 - $71.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
450.73x
P/B ratio:
5.72x
Volume:
3M
Avg. volume:
7.9M
1-year change:
94.22%
Market cap:
$10.8B
Revenue:
$10.9M
EPS (TTM):
-$4.17

Earnings Data

Next earnings date for RNA
Mar 02
2026
Most recent earnings per share
-$1.27
Missed by $0.16
(Nov 10/2025)
Consensus Estimate
-$1.10
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RNA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/02/2026 Q4 $2M -- -- -$1.28 --
11/10/2025 Q3 $1.8M $12.5M -$1.27 -$1.10 -$0.16
08/08/2025 Q2 $1.6M $3.8M -$1.21 -$0.96 -$0.26
05/08/2025 Q1 $2.6M $1.6M -$0.90 -$0.88 -$0.02
02/27/2025 Q4 $1.7M $3M -$0.80 -$0.78 -$0.01
11/07/2024 Q3 $4.6M $2.3M -$0.65 -$0.72 $0.07
08/09/2024 Q2 $3M $2M -$0.66 -$0.78 $0.12
05/09/2024 Q1 $2.6M $3.5M -$0.79 -$0.88 $0.09
02/28/2024 Q4 $12.2M $2.2M -$0.79 -$0.63 -$0.16
11/08/2023 Q3 $1.8M $2.8M -$0.71 -$0.75 $0.04
08/08/2023 Q2 -- $2.3M -$0.66 -- --
05/09/2023 Q1 -- $2.2M -$0.74 -- --
02/28/2023 Q4 -- $2.8M -$0.88 -- --
11/08/2022 Q3 -- $2.5M -$0.82 -- --
08/09/2022 Q2 -- $2.2M -$0.92 -- --
05/10/2022 Q1 -- $1.8M -$0.71 -- --
03/01/2022 Q4 -- $1.9M -$0.82 -- --
11/09/2021 Q3 -- $2.2M -$0.68 -- --
08/09/2021 Q2 -- $2.6M -$0.70 -- --
05/12/2021 Q1 -- $2.7M -$0.64 -- --
03/15/2021 Q4 -- $2.1M -$0.43 -- --
11/10/2020 Q3 -- $1.7M -$0.31 -- --
08/10/2020 Q2 -- $1.5M -$0.28 -- --
03/31/2020 Q1 -- $1.4M -$0.16 -- --
12/31/2019 Q4 -- -- -$0.50 -- --
09/30/2019 Q3 -- $650K -$2.43 -- --
06/30/2019 Q2 -- $224K -$0.14 -- --
03/31/2019 Q1 -- -- -$0.07 -- --

Avidity Biosciences, Inc. Earnings Questions

  • How Much did Avidity Biosciences, Inc. Generate in Revenue Last Quarter?

    Avidity Biosciences, Inc. reported $12.5M worth of top line sales in its most recent quarter.

  • Did Avidity Biosciences, Inc. Beat Earnings Last Quarter?

    Avidity Biosciences, Inc. announced earnings per share of -$1.27 which represents a miss of analyst forecast a -$1.10 per share.

  • Is Avidity Biosciences, Inc. Profitable?

    Avidity Biosciences, Inc. reported $11.4M that represents $0.08 per share over the last quarter.

  • What is the Analyst Consensus for Avidity Biosciences, Inc. EPS Next Year?

    Avidity Biosciences, Inc.'s earnings are forecast to decrease from -$2.89 per share to -$2.86 per share next year representing a decrease of -55.39%.

  • When is Avidity Biosciences, Inc.'s Earnings Date?

    Avidity Biosciences, Inc.'s next earnings date is March 2, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.

Sell
13
PSN alert for Dec 8

Parsons Corp. [PSN] is down 5.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock